文献速递泌尿生殖MR

假阴性mpMRI男性的前列腺癌危险因素:一项关于图像质量评分与临床参数的回顾性单中心队列研究

Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters.
PubMed 文献 · Eur J Radiol · 2023-11-28

该回顾性单中心研究纳入96例mpMRI阴性(PI-RADS≤2)后行前列腺活检的患者,活检病理显示44.8%为前列腺癌、16.7%为临床显著前列腺癌。前列腺癌和临床显著前列腺癌患者的PI-QUAL评分显著更低,低PI-QUAL是假阴性mpMRI漏诊临床显著前列腺癌的唯一独立预测因子。

要点

  • 假阴性mpMRI患者中活检证实前列腺癌占44.8%、临床显著前列腺癌占16.7%。
  • 前列腺癌患者PI-QUAL评分显著低于无前列腺癌者(p=0.03)。
  • 低PI-QUAL评分是假阴性mpMRI漏诊临床显著前列腺癌的唯一独立预测因子。

核心结论

  • 在假阴性mpMRI患者中,较低图像质量评分与漏诊前列腺癌/临床显著前列腺癌相关,PI-QUAL是临床显著前列腺癌漏诊的独立预测因子,凸显前列腺MRI图像质量的重要性并提倡将其测量纳入标准化报告。

研究设计与样本

  • IRB批准的回顾性单中心队列研究,纳入96例mpMRI阴性(PI-RADS评分≤2)且随后行前列腺活检的患者,以组织病理学结果为参考标准,比较有无前列腺癌/临床显著前列腺癌患者间PI-QUAL和PSHS图像质量评分的差异,并行单因素和多因素分析。

诊断标准与关键数值

  • mpMRI阴性定义为PI-RADS评分≤2;采用PI-QUAL和PSHS两种图像质量评分系统;前列腺癌患者PI-QUAL评分显著低于无前列腺癌者(p=0.03),临床显著前列腺癌患者PI-QUAL评分显著低于无临床显著前列腺癌者(p=0.005);临床显著前列腺癌患者PSHS评分较低但差异无统计学意义(p=0.1);较高年龄(p=0.035)和较低PI-QUAL评分(p<0.004)为活检检出临床显著前列腺癌的预测因子,低PI-QUAL是假阴性mpMRI漏诊临床显著前列腺癌的唯一独立预测因子。

临床应用与阅片要点

  • 作者提倡将图像质量测量(PI-QUAL)纳入前列腺MRI标准化报告,以关注图像质量对假阴性mpMRI漏诊临床显著前列腺癌的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To identify predictors of prostate cancer (PCa) and clinically significant prostate cancer (csPCa) in men with prior false-negative multiparametric MRI (mpMRI), focusing on image quality scoring systems and clinical parameters.

METHODS: In this IRB-approved retrospective single-center study, patients with a negative mpMRI (PI-RADS score ≤2) and subsequent prostate biopsies were included. Histopathological results served as reference standard. Welch's t-Test was conducted to identify significant differences in image quality scores (PI-QUAL and PSHS) between patients with and without PCa/csPCA. In addition, clinical parameters (age, BMI, PSA density) and image quality scores (PI-QUAL and PSHS) were examined as potential predictors of PCa/csPCa detection after a false-negative mpMRI in uni- and multivariate analyses.

RESULTS: Among 96 patients with negative mpMRI results, 44.8 % had PCa and 16.7 % had csPCa upon biopsy with histopathological confirmation. PI-QUAL scores were significantly lower in patients with PCa (p = 0.03) and csPCa (p = 0.005). PSHS scores were lower in patients with csPCa, but the difference was not statistically significant (p = 0.1). Higher age (p = 0.035) and a lower PI-QUAL score (p < 0.004) were predictors of subsequent csPCa detection upon biopsy, however, a lower PI-QUAL score was the only independent predictor of missed csPCa in false-negative mpMRIs.

CONCLUSIONS: Lower image quality scores were associated with missed PCa/csPCa in patients with false-negative mpMRIs, with PI-QUAL being an independent predictor of failed csPCa detection. This highlights the importance of image quality for prostate MRI and advocats the inclusion of its measurement into the standardized report.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Pausch AM, Ghafoor S, Kluckert J, et al. Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters. Eur J Radiol. 2023. PMID: 38039782. doi:10.1016/j.ejrad.2023.111227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。